IMUGENE CHART. TA only, page-9323

Hahaha, you seriously are a clown.

I guess you're "no news" doesn't take into account the numerous significant announcements over the 8 week period (between 1/9 and 1/11) when the share price went from 40c to 60c including:

* Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials.
* S&P DJI Announces September 2021 Quarterly Rebalance
* First patient dosed in Phase 1 clinical trial of CHECKVACC.
* Imugene HER-Vaxx Immunotherapy Patent Granted in Japan.
* Imugene and Eureka Therapeutics onCARlytics Collaboration

Hope you're little pip trades are better than your commentary.